{"abstract": "Samuel D. Waksal\u2019s new company, Kadmon Pharmaceuticals, said that it had acquired Three Rivers Pharmaceuticals, which mainly sells drugs to treat hepatitis C.", "web_url": "https://www.nytimes.com/2010/10/26/business/26drug.html", "snippet": "Samuel D. Waksal\u2019s new company, Kadmon Pharmaceuticals, said that it had acquired Three Rivers Pharmaceuticals, which mainly sells drugs to treat hepatitis C.", "lead_paragraph": "Samuel D. Waksal, the biotechnology executive whose insider trading landed him and his friend Martha Stewart in prison, is trying to make a comeback.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Former ImClone Chief Acquires Drug Company", "kicker": null, "content_kicker": null, "print_headline": "Former ImClone Chief Acquires Drug Company", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "ImClone Systems Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Securities and Commodities Violations", "rank": 4, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 5, "major": "N"}, {"name": "persons", "value": "Waksal, Samuel", "rank": 6, "major": "N"}], "pub_date": "2010-10-25T23:49:42+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By The New York Times", "person": [], "organization": "The New York Times"}, "type_of_material": "News", "_id": "nyt://article/ace0ae14-dc9a-5158-9937-2e54fe302c41", "word_count": 424, "uri": "nyt://article/ace0ae14-dc9a-5158-9937-2e54fe302c41"}